I don't know if you could request it yet. Any human therapy has to go through a sufficiently controlled human trial to show that it doesn't introduce harms before you can introduce it as standard of care -- and there's not supposed to be any adoption of therapies until those trials are completed. If this study meets those criteria then it will make it through hospital IRBs and be adopted as the new standard of care.
That sounds like I'm being a stickler for rules when babies are dying. But. An awful lot of docs recommended and people adopted, in an uncontrolled experimental fashion, antioxidant therapies, on the grounds that they couldn't hurt and might help, based on some small studies. And then the big studies showed that actually, they *could* hurt. Mostly this disease is just so counterintuitive that docs have gotten a lot more cautious. The HYPITAT study one of the only ones where I'd expect printing it out to potentially change an individual practice, and that's because induction at term for maternal indicators is already an accepted practice, if that makes sense.